Clexane 40mg (Enoxaparin): Uses, Dosing, Renal Adjustment, and Reversal

Clexane 40 mg (enoxaparin sodium) is a low molecular weight heparin (LMWH) administered subcutaneously. It potentiates antithrombin III → inhibits Factor Xa and thrombin (IIa) — preventing clot formation/extension.

Approved Indications

  • Prophylaxis of DVT: Abdominal, orthopedic (hip/knee replacement), general surgery patients with risk factors
  • Prophylaxis of DVT in medical patients: Acute illness, immobility (e.g., heart failure, respiratory failure, stroke, infection)
  • Treatment of acute DVT ± PE: 1 mg/kg q12h (40 mg is prophylactic dose only)
  • Unstable angina / NSTEMI: 1 mg/kg q12h + aspirin
  • STEMI: 30 mg IV bolus + 1 mg/kg SC q12h (age <75)
  • Pregnancy-associated VTE prophylaxis/treatment: Preferred anticoagulant (doesn’t cross placenta)
  • Hemodialysis: Prevents circuit clotting

Key Points

  • 40 mg = prophylactic dose. Therapeutic dose is weight-based (1 mg/kg q12h).
  • Renal adjustment: CrCl <30 mL/min → reduce dose / monitor anti-Xa.
  • Monitoring: Anti-Xa levels (therapeutic); not routine for prophylaxis.
  • Reversal: Andexanet alfa (full); protamine sulfate (partial, ~60%).
  • Contraindications: Active major bleeding, HIT, severe thrombocytopenia, hypersensitivity.

Always prescribe per indication, weight, renal function, and guidelines (ACCP, ESC).

Prescription Medications - Related Articles